KATHY BANNON: Open Payments
NPI 1639832025 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,261 in 168 payments from 41 companies in 2025. Trend: 2023 $2,735 · 2024 $4,489 · 2025 $4,261
Food & beverage: $3,082Long term medical supply or device loan: $1,000Education: $180
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $1,248 |
| PFIZER INC. | 19 | $315 |
| Merck Sharp & Dohme LLC | 14 | $260 |
| GlaxoSmithKline, LLC. | 8 | $227 |
| Janssen Biotech, Inc. | 5 | $197 |
| AstraZeneca Pharmaceuticals LP | 8 | $195 |
| Eisai Inc. | 5 | $176 |
| Gilead Sciences, Inc. | 6 | $168 |
| Boston Scientific Corporation | 1 | $132 |
| Alexion Pharmaceuticals, Inc. | 5 | $106 |
Products named: KISQALI, KEYTRUDA, Lenvima, Trodelvy, ELREXFIO, ZEJULA, WATCHMAN FLX, ULTOMIRIS.
Industry payments across IN — which companies pay providers there.
